Amedeo Smart

Free Medical Literature Service

 

Amedeo

Gynecology
  Free Subscription

Articles published in
Int J Oncol
    December 2024
  1. LIU Y, Xiao H, Zeng H, Xiang Y, et al
    Beyond tumor?associated macrophages involved in spheroid formation and dissemination: Novel insights for ovarian cancer therapy (Review).
    Int J Oncol. 2024;65:117.
    >> Share

    November 2024
  2. ZHU Y, Yang W, Wang X, Chen M, et al
    AUP1 transcriptionally activated by KDM5B reprograms lipid metabolism to promote the malignant progression of cervical cancer.
    Int J Oncol. 2024;65:107.
    >> Share

  3. TAN H, He Q, Gong G, Wang Y, et al
    [Corrigendum] miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer.
    Int J Oncol. 2024;65:110.
    >> Share

    October 2024
  4. SUN J, Chu H, Ji J, Huo G, et al
    [Retracted] Long non?coding RNA HOTAIR modulates HLA?G expression by absorbing miR?148a in human cervical cancer.
    Int J Oncol. 2024;65:97.
    >> Share

    August 2024
  5. XU S, Zhu C, Xu Q, An Z, et al
    ARID1A restrains EMT and stemness of ovarian cancer cells through the Hippo pathway.
    Int J Oncol. 2024;65:76.
    >> Share

    June 2024
  6. FU M, Deng F, Chen J, Fu L, et al
    Current data and future perspectives on DNA methylation in ovarian cancer (Review).
    Int J Oncol. 2024;64:62.
    >> Share

    March 2024
  7. GRUNT TW, Wagner R, Ries A, Berghoff AS, et al
    Targeting endogenous fatty acid synthesis stimulates the migration of ovarian cancer cells to adipocytes and promotes the transport of fatty acids from adipocytes to cancer cells.
    Int J Oncol. 2024;64:24.
    >> Share

  8. GENG D, Zhou Y, Wang M
    Advances in the role of GPX3 in ovarian cancer (Review).
    Int J Oncol. 2024;64:31.
    >> Share

  9. INOUE F, Sone K, Kumegawa K, Hachijo R, et al
    Inhibition of protein arginine methyltransferase 6 activates interferon signaling and induces the apoptosis of endometrial cancer cells via histone modification.
    Int J Oncol. 2024;64:32.
    >> Share

    January 2024
  10. LIU Y, Yang Y, Wang X, Yin S, et al
    Function of microRNA?124 in the pathogenesis of cancer (Review).
    Int J Oncol. 2024;64:6.
    >> Share

    December 2023
  11. QI Y, Ma N, Zhang J
    Tripartite motif containing 33 demonstrated anticancer effect by degrading c?Myc: Limitation of glutamine metabolism and proliferation in endometrial carcinoma cells.
    Int J Oncol. 2023;63:133.
    >> Share

  12. LIANG T, Lu T, Jia W, Li R, et al
    Knockdown of lncRNA MALAT1 induces pyroptosis by regulating the miR?124/SIRT1 axis in cervical cancer cells.
    Int J Oncol. 2023;63:138.
    >> Share

    November 2023
  13. DENG F, Fu M, Zhao C, Lei J, et al
    Calcium signals and potential therapy targets in ovarian cancer (Review).
    Int J Oncol. 2023;63:125.
    >> Share

    October 2023
  14. YUAN J, Guan W, Li X, Wang F, et al
    RBM15‑mediating MDR1 mRNA m(6)A methylation regulated by the TGF‑beta signaling pathway in paclitaxel‑resistant ovarian cancer.
    Int J Oncol. 2023;63:112.
    >> Share

    September 2023
  15. O'DONNELL J, Zhao Z, Buckingham L, Hao T, et al
    Ipatasertib exhibits anti‑tumorigenic effects and enhances sensitivity to paclitaxel in endometrial cancer in vitro and in vivo.
    Int J Oncol. 2023;63:103.
    >> Share

    August 2023
  16. ZHAI L, Yang X, Dong J, Qian L, et al
    O‑GlcNAcylation mediates endometrial cancer progression by regulating the Hippo‑YAP pathway.
    Int J Oncol. 2023;63:90.
    >> Share

    May 2023
  17. CHEN Q, Shen S, Lv N, Tong J, et al
    Role of microRNAs in glycolysis in gynecological tumors (Review).
    Int J Oncol. 2023;62:63.
    >> Share

    December 2022
  18. KARIN-KUJUNDZIC V, Covarrubias-Pinto A, Skrtic A, Vranic S, et al
    New insight into the role of PTCH1 protein in serous ovarian carcinomas.
    Int J Oncol. 2022;61.
    >> Share

  19. SHEN S, Guo J, Lv N, Chen Q, et al
    RNA m6A methylation regulators in endometrial cancer (Review).
    Int J Oncol. 2022;61.
    >> Share

    November 2022
  20. ENDO Y, Sugimoto K, Kobayashi M, Kobayashi Y, et al
    Claudin9 is a novel prognostic biomarker for endometrial cancer.
    Int J Oncol. 2022;61.
    >> Share

    October 2022
  21. WANG Y, Han A, Chen E, Singh RK, et al
    [Corrigendum] The cranberry flavonoids PAC DP9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells.
    Int J Oncol. 2022;61.
    >> Share

  22. LI R, Wang Y, Xu Y, He X, et al
    [Retracted] Silencing the long noncoding RNA, TINCR, a molecular sponge of miR335, inhibits the malignant phenotype of epithelial ovarian cancer via FGF2 suppression.
    Int J Oncol. 2022;61.
    >> Share

  23. BJERSAND K, Blom K, Poromaa IS, Stalberg K, et al
    Ex vivo assessment of cancer drug sensitivity in epithelial ovarian cancer and its association with histopathological type, treatment history and clinical outcome.
    Int J Oncol. 2022;61.
    >> Share

  24. KIM SH, Baek KH
    Ovarian tumor deubiquitinase 6A regulates cell proliferation via deubiquitination of nucleolin and caspase7.
    Int J Oncol. 2022;61.
    >> Share

    July 2022
  25. XU L, Li J, Tursun M, Hai Y, et al
    Receptor for activated C kinase 1 promotes cervical cancer lymph node metastasis via the glycolysisdependent AKT/mTOR signaling.
    Int J Oncol. 2022;61.
    >> Share

  26. FEDIER A, Maggi N, Tozzi A, Disler M, et al
    Exposure to escalating olaparib does not induce acquired resistance to PARPi and to other chemotherapeutic compounds in ovarian cancer cell lines.
    Int J Oncol. 2022;61.
    >> Share

    May 2022
  27. ZHANG R, Roque DM, Reader J, Lin J, et al
    Combined inhibition of IL6 and IL8 pathways suppresses ovarian cancer cell viability and migration and tumor growth.
    Int J Oncol. 2022;60.
    >> Share

  28. LAVORO A, Scalisi A, Candido S, Zanghi GN, et al
    Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families?
    Int J Oncol. 2022;60.
    >> Share

    March 2022
  29. LI L, Yu J, Duan Z, Dang HX, et al
    [Corrigendum] The effect of NFATc1 on vascular generation and the possible underlying mechanism in epithelial ovarian carcinoma.
    Int J Oncol. 2022;60.
    >> Share

  30. SINGH T, Neal A, Dibernardo G, Raheseparian N, et al
    Efficacy of birinapant in combination with carboplatin in targeting platinumresistant epithelial ovarian cancers.
    Int J Oncol. 2022;60.
    >> Share

    January 2022
  31. FAN LX, Tao L, Lai YC, Cai SY, et al
    Cx32 promotes autophagy and produces resistance to SNinduced apoptosis via activation of AMPK signalling in cervical cancer.
    Int J Oncol. 2022;60.
    >> Share

    July 2021
  32. FALZONE L, Scandurra G, Lombardo V, Gattuso G, et al
    A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer (Review).
    Int J Oncol. 2021;59.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016